Tech Company Financing Transactions
SAVA Funding Round
SAVA, based in London, secured $36 million from Ascensia, Balderton Capital and Jamjar Investments.
Transaction Overview
Company Name
Announced On
10/9/2026
Transaction Type
Venture Equity
Amount
$36,000,000
Round
Series B
Investors
Ascensia (Lead Investor) (Peter Bodlund)
Proceeds Purpose
The company plans to use this capital to fund manufacturing scale-up and commercial readiness.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
117 Charterhouse Street
London, EC1M 6AA
UK
London, EC1M 6AA
UK
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
All the health information we need is within us. Just below the skin. SAVA is redefining the way people interact with their health by developing the most advanced biosensing technology science has to offer, capable of accessing bodily information in a painless, real-time and affordable way.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Renato Circi
Co-Founder
Rafael Michali
Browse more venture capital transactions:
Prev: 10/8/2026: Rein Security venture capital transaction
Next: 10/9/2026: Welltory venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs